Current Opinion in Pharmacology

Papers
(The H4-Index of Current Opinion in Pharmacology is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
From “contraindicated” to “first line” – Current mechanistic insights beyond canonical β-receptor signaling92
Native botulinum toxin type A vs. redesigned botulinum toxins in pain: What did we learn so far?86
Editorial Board75
The role of extracellular ATP in homeostatic immune cell migration60
Therapeutic Hurdles in Acute Myeloid Leukemia: Leukemic Stem Cells, Inflammation and Immune Dysfunction58
The P2X7 purinoceptor in pathogenesis and treatment of dystrophino- and sarcoglycanopathies57
Splice-switching as cancer therapy44
Lipid raft disruption as an opportunity for peripheral analgesia43
Recent advances in emerging PCOS therapies42
Gastrointestinal issue: Advances in gastrointestinal oncology34
Optofluidic neural interfaces for in vivo photopharmacology33
Editorial Board33
Artemisinins and their impact on inhibitory neurotransmission32
Technological advancements to study cellular signaling pathways in inherited retinal degenerative diseases31
Current status of hepatitis delta31
Photo-isomerizable tweezers to probe ionotropic receptor mechanisms29
Three-dimensional culture models to study glioblastoma — current trends and future perspectives29
Optic nerve regeneration: Potential treatment approaches29
Considerations for individualized first-line systemic treatment in advanced hepatocellular carcinoma29
Pancreatic alpha cells and glucagon secretion: Novel functions and targets in glucose homeostasis29
Editorial overview: Special issue on “Rheumatology: Therapeutic advances for autoimmune and musculoskeletal diseases”29
Dyslipidemia and diabetes mellitus: Role of lipoprotein species and interrelated pathways of lipid metabolism in diabetes mellitus28
Emerging mutations in the SARS-CoV-2 variants and their role in antibody escape to small molecule-based therapeutic resistance28
Editorial Board26
Pharmaceutical therapies targeting autophagy for the treatment of age-related macular degeneration26
A review of emerging neuroprotective and neuroregenerative therapies in traumatic spinal cord injury26
0.091023921966553